In support of this notion, common mutations in the HIF-α binding domain of pVHL that fall within the type 2A disease phenotype result in higher levels of HIF-α, yet are associated with a low incidence of RCC [23]. The gene discussed is VHL; the disease is renal cell carcinoma.